|
US2011008372A1
|
|
Enhancement of light activated drug therapy through combination with other therapeutic agents
|
|
US2011009464A1
|
|
Immune system stimulation by light therapy induced apoptotic cell death in abnormal tissue
|
|
US2010036311A1
|
|
Enhancement of light activated therapy by immune augmentation using anti-CTLA-4 antibody
|
|
WO2009036396A1
|
|
Systems, devices, and methods for photoactive assisted resection
|
|
US2008269846A1
|
|
Device for treatment of blood vessels using light
|
|
WO2008086375A2
|
|
Non-invasive vascular treatment systems, devices, and methods of using the same
|
|
WO2008046019A1
|
|
Light delivery apparatus and methods for illuminating internal tissues
|
|
CN101490057A
|
|
Compositions and methods of making a photoactive agent
|
|
EP1933894A2
|
|
Implantable device for therapeutic treatment within a body lumen
|
|
US2007225777A1
|
|
PDT apparatus with high output LED for therapy and aiming
|
|
KR20070112194A
|
|
Photoreactive system and methods for prophylactic treatment of atherosclerosis
|
|
MX2007008061A
|
|
Medical apparatus employing flexible light structures and methods for manufacturing same.
|
|
EP1827417A1
|
|
Enhanced occlusive effect photodynamic therapy
|
|
US2005240247A1
|
|
Fractionated light PDT therapy for posterior eye disease
|
|
US2009192209A1
|
|
Extended treatment of tumors through vessel occlusion with light activated drugs
|
|
AU2004275804A1
|
|
Conjugates for photodynamic therapy
|
